Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Pietropaolo

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
Plos One|July 17, 2010
Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching methodBetty Tao, Massimo Pietropaolo, Mark Atkinson, et al.
European Journal of Cell Biology|January 12, 2008
ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cellsLaura Buffa, Evelyn Fuchs, Massimo Pietropaolo, et al.
Pediatric Diabetes|May 16, 2014
Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseMajid Jaberi-Douraki, Shang Wan Shalon Liu, Massimo Pietropaolo, et al.
Diabetes|October 31, 2008
Primer: immunity and autoimmunityMassimo Pietropaolo, Julie M Surhigh, Patrick W Nelson, et al.
Biochemistry and Biophysics Reports|December 29, 2022
Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion proteinThilini Mendis, Barbora Filipova, Jing Jing Wang, et al.
The Journal of Biological Chemistry|November 1, 2002
Alternative core promoters regulate tissue-specific transcription from the autoimmune diabetes-related ICA1 (ICA69) gene locusRobert P Friday, Susan L Pietropaolo, Jennifer Profozich, et al.
Journal of the Endocrine Society|November 23, 2020
Checking the Checkpoint Inhibitors: A Case of Autoimmune Diabetes After PD-1 Inhibition in a Patient with HIVMichael S Hughes, Massimo Pietropaolo, Madhuri M Vasudevan, et al.
Current Diabetes Reports|December 13, 2021
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes EndotypesAlessandra Petrelli, Anna Giovenzana, Vittoria Insalaco, et al.
Diabetes Care|April 24, 2019
Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640Surya N Mulukutla, Maria Acevedo-Calado, Christiane S Hampe, et al.
Mathematical Biosciences and Engineering : MBE|October 20, 2009
Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responsesPatrick Nelson, Noah Smith, Stanca Ciupe, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Plos One|July 17, 2010
Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching methodBetty Tao, Massimo Pietropaolo, Mark Atkinson, et al.
European Journal of Cell Biology|January 12, 2008
ICA69 is a novel Rab2 effector regulating ER-Golgi trafficking in insulinoma cellsLaura Buffa, Evelyn Fuchs, Massimo Pietropaolo, et al.
Pediatric Diabetes|May 16, 2014
Autoimmune responses in T1DM: quantitative methods to understand onset, progression, and prevention of diseaseMajid Jaberi-Douraki, Shang Wan Shalon Liu, Massimo Pietropaolo, et al.
Diabetes|October 31, 2008
Primer: immunity and autoimmunityMassimo Pietropaolo, Julie M Surhigh, Patrick W Nelson, et al.
Biochemistry and Biophysics Reports|December 29, 2022
Affinity purification of serum-derived anti-IA-2 autoantibodies in type 1 diabetes using a novel MBP-IA-2 fusion proteinThilini Mendis, Barbora Filipova, Jing Jing Wang, et al.
The Journal of Biological Chemistry|November 1, 2002
Alternative core promoters regulate tissue-specific transcription from the autoimmune diabetes-related ICA1 (ICA69) gene locusRobert P Friday, Susan L Pietropaolo, Jennifer Profozich, et al.
Journal of the Endocrine Society|November 23, 2020
Checking the Checkpoint Inhibitors: A Case of Autoimmune Diabetes After PD-1 Inhibition in a Patient with HIVMichael S Hughes, Massimo Pietropaolo, Madhuri M Vasudevan, et al.
Current Diabetes Reports|December 13, 2021
Autoimmune Inflammation and Insulin Resistance: Hallmarks So Far and Yet So Close to Explain Diabetes EndotypesAlessandra Petrelli, Anna Giovenzana, Vittoria Insalaco, et al.
Diabetes Care|April 24, 2019
Response to Comment on Mulukutla et al. Autoantibodies to the IA-2 Extracellular Domain Refine the Definition of "A+" Subtypes of Ketosis-Prone Diabetes. Diabetes Care 2018;41:2637-2640Surya N Mulukutla, Maria Acevedo-Calado, Christiane S Hampe, et al.
Mathematical Biosciences and Engineering : MBE|October 20, 2009
Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responsesPatrick Nelson, Noah Smith, Stanca Ciupe, et al.
Pageof 8